Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php |
Title | Dimerix |
Description | Dimerix is a clinical-stage biopharmaceutical company, with multiple Phase 3 opportunities, Dimerix is a public a biopharmaceutical company, with multiple Phase 3 opportunities, working on advancing new drug therapies for unmet medical |
Keywords | N/A |
WebSite | dimerix.com |
Host IP | 101.0.109.50 |
Location | Australia |
Site | Rank |
US$2,466,795
Last updated: 2022-06-29 20:07:03
dimerix.com has Semrush global rank of 4,290,711. dimerix.com has an estimated worth of US$ 2,466,795, based on its estimated Ads revenue. dimerix.com receives approximately 284,631 unique visitors each day. Its web server is located in Australia, with IP address 101.0.109.50. According to SiteAdvisor, dimerix.com is safe to visit. |
Purchase/Sale Value | US$2,466,795 |
Daily Ads Revenue | US$2,278 |
Monthly Ads Revenue | US$68,312 |
Yearly Ads Revenue | US$819,735 |
Daily Unique Visitors | 18,976 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
dimerix.com. | A | 299 | IP: 101.0.109.50 |
dimerix.com. | NS | 86400 | NS Record: opal.ns.cloudflare.com. |
dimerix.com. | NS | 86400 | NS Record: arturo.ns.cloudflare.com. |
dimerix.com. | MX | 300 | MX Record: 1 dimerix-com.mail.protection.outlook.com. |
dimerix.com. | TXT | 300 | TXT Record: MS=ms47093758 |
dimerix.com. | TXT | 300 | TXT Record: hes=706782aaba3e007057a3b0820dda3e3d |
dimerix.com. | TXT | 300 | TXT Record: MS=3155A0E1076BA7819E611ED7C48946FCAD734659 |
dimerix.com. | TXT | 300 | TXT Record: v=spf1 a mx include:spf.protection.outlook.com include:_spf.createsend.com ~all |
You are using an outdated browser. Please upgrade your browser to improve your experience. About Board / Management Company Strategy Technology Pipeline DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) DMX-200 for COVID Pneumonia Respiratory Complications DMX-200 for Focal Segmental Glomerulosclerosis (FSGS) Partnering Investor Centre Announcements & Media Releases Share Price & Graph Investor Services Corporate Governance Board & Management Corporate Factsheet Contact Us About Board / Management Company Strategy Technology Pipeline DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) DMX-200 for COVID Pneumonia Respiratory Complications DMX-200 for Focal Segmental Glomerulosclerosis (FSGS) Partnering Investor Centre Announcements & Media Releases Share Price & Graph Investor Services Corporate Governance Board & Management Corporate Factsheet Contact Us Dimerix is a clinical-stage biopharmaceutical company, with multiple Phase 3 opportunities, developing innovative new |
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 20:01:40 GMT Server: Apache Expires: Tue, 26 Oct 2021 21:01:40 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Location: https://dimerix.com/ Referrer-Policy: no-referrer-when-downgrade Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Tue, 26 Oct 2021 20:01:41 GMT Server: Apache Last-Modified: Tue, 26 Oct 2021 19:38:22 GMT ETag: "5565-5cf469ecafc7a" Accept-Ranges: bytes Content-Length: 21861 Cache-Control: max-age=172800 Expires: Thu, 28 Oct 2021 20:01:41 GMT Vary: Accept-Encoding,User-Agent Referrer-Policy: no-referrer-when-downgrade Content-Type: text/html; charset=UTF-8 |
Domain Name: DIMERIX.COM Registry Domain ID: 110297092_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.arq.group Registrar URL: http://www.melbourneit.com.au Updated Date: 2021-03-08T15:05:03Z Creation Date: 2004-01-21T07:32:59Z Registry Expiry Date: 2026-01-21T07:32:59Z Registrar: Webcentral Group Limited dba Melbourne IT Registrar IANA ID: 13 Registrar Abuse Contact Email: abuse@melbourneit.com.au Registrar Abuse Contact Phone: +61342060102 Domain Status: ok https://icann.org/epp#ok Name Server: ARTURO.NS.CLOUDFLARE.COM Name Server: OPAL.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T19:31:46Z <<< |